Construction of Doxorubicin-conjugated Lentinan Nanoparticles for Enhancing the Cytotoxocity Effects Against Breast Cancer Cells

Publication date: Available online 14 July 2019Source: Colloids and Surfaces A: Physicochemical and Engineering AspectsAuthor(s): Ying Wang, Jingwen Chen, Qianqian Han, Qiang Luo, Hongmei Zhang, Yanqing WangAbstractLentinan(LNT) has many kinds of pharmacological activities such as antioxidative activities, hypoglycemic effect, anti-hyperlipidemic effect and so on. Here, LNT was used as the skeleton material to couple with doxorubicin(DOX) by forming the LNT–DOX conjugates in order to enhance anticancer effects and reduce the systemic side effects of DOX. Based on the screening results, we observed that LNT can acted as an antitumor carrier for release of DOX with pH-responsive. DOX release from conjugates was 63.1% at pH 5.0 for up to 48 h, whereas 13.6% of DOX release was observed at pH 7.4 in phosphate buffered saline. The grafting rate of LNT-DOX conjugates was 6.5±0.65 mg/100 mg DOX content. The morphology results showed that LNT-DOX conjugates were considerably more amorphous than LNT. LNT linked by DOX basically maintained the original structure and rheology in water solution. The in vitro anticancer activity of LNT–DOX conjugates was higher than that of free DOX. It is important that LNT–DOX conjugates can enhance anticancer effects in breast cancer cells and decrease the cytotoxocity effects against human normal cells. This work proved that the LNT–DOX conjugates might be suitable for building anticancer drug platform in the course of ch...
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects - Category: Chemistry Source Type: research

Related Links:

CONCLUSION: The study identified both a high prevalence of xerostomia regardless of the chemotherapy used and the need to create protocols to improve the quality of life of these patients. PMID: 32965427 [PubMed - in process]
Source: Revista Brasileira de Enfermagem - Category: Nursing Authors: Tags: Rev Bras Enferm Source Type: research
Condition:   Musculoskeletal Pain Intervention:   Drug: Etoricoxib Sponsor:   Guangdong Provincial People's Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: Journal of Computational and Theoretical Nanoscience - Category: Nanotechnology Authors: Tags: research-article Source Type: research
Conclusions: Our study demonstrated rs6484711 polymorphism regulating ABTB2 expression might predict efficacy to epirubicin based NAC in luminal A breast cancer patients. These results provided valuable information about potential role of genetic variations in individualized chemotherapy.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Cell Death &Disease, Published online: 25 September 2020; doi:10.1038/s41419-020-03004-9FZR1 as a novel biomarker for breast cancer neoadjuvant chemotherapy prediction
Source: Cell death and disease - Category: Internal Medicine Authors: Source Type: research
AbstractBreast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women ’s attendance to organised mammography screening as well as to advances in therapies, especially systemic treatments. Screening attendance is associated with a mortality reduction of at least 30% and a 40% lower risk of advanced disease. The stage at diagnosis remains the strongest predictor of re currences. Systemic treatments evolved dramatically over the last 20 years: aromatase inhibitors...
Source: Insights into Imaging - Category: Radiology Source Type: research
Kazuaki Takabe Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with higher mortality than the others. Pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is considered as a surrogate to predict survival. Inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) is a negative regulator of T cell activation, and reduction in ITPKC function is known to promote Kawasaki disease. Given the role of tumor infiltrating lymphocytes in NAC and since TNBC has the most abundant immune cell infiltration in breast cancer, we hypothesized that the ITPKC expression level is associated wit...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
Photochem. Photobiol. Sci., 2020, Accepted Manuscript DOI: 10.1039/D0PP00132E, PaperArghavan Yousefi Sadeghloo, khatereh khorsandi, Zahra Kianmehr Breast cancer is metastatic cancer that can spreads to other organs such as bone, liver, and brain. There are many treatments for breast cancer such as surgery and chemotherapy, but... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Photochem. Photobiol. Sci. latest articles - Category: Chemistry Authors: Source Type: research
Am J Perinatol DOI: 10.1055/s-0040-1717075 Objective Breast cancer is one of the most frequently diagnosed cancers in pregnancy and is commonly treated with chemotherapy. To date, studies examining effects of chemotherapy during pregnancy on fetal growth have yielded conflicting results, and most are limited by small sample sizes or are nonspecific with respect to cytotoxic regimen or type of cancer treated. We sought to evaluate the effect of chemotherapy for breast cancer in pregnancy on birthweight and small for gestational age infants. Study Design This is a retrospective cohort study of 74 women diagno...
Source: American Journal of Perinatology - Category: Perinatology & Neonatology Authors: Tags: Original Article Source Type: research
Conclusions: Patients with metastatic breast cancer should perform re-biopsy to clarify the receptor status of the first metastatic lesions, which may provide clinicians valuable evidence to conduct treatments with higher precision.Oncol Res Treat
Source: Oncology Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemistry | Chemotherapy | Nanotechnology